4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-18-017207
Executive VP, Global R&D gave up 1,555 shares (to pay taxes)
- Executive VP, Global R&D acquired 4,597 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Fridriksdottir Hafrun · Executive VP, Global R&D
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-03-04 | Exercise or conversion : show line 1 in the form | +1,165 | 4,509.51 | D | ||
| 2018-03-05 | Exercise or conversion : show line 2 in the form | +3,432 | 7,941.51 | D | ||
| 2018-03-05 | Shares withheld for taxes : show line 3 in the form | −400 | $19.38 | $7,752 | 7,541.51 | D |
| 2018-03-05 | Shares withheld for taxes : show line 4 in the form | −1,155 | $19.38 | $22,384 | 6,386.51 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-03-04 | Exercise or conversion : show line 5 in the form Restricted Share Units | −1,165 | 1,165 | D |
| 2018-03-05 | Exercise or conversion : show line 6 in the form Restricted Share Units | −3,432 | 0 | D |
Loading xslF345X03/doc4.xml…